PLURYAL references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
Pluryal Hair Density
Pluryal Hair Density is a sterile, ready-to-use, CE-marked injectable polynucleotide (PN) biostimulator, formulated for scalp and hair regeneration. It is reserved for medical practitioners only and is indicated for hair loss conditions such as androgenetic alopecia and telogen effluvium, as well as for support after hair transplantation. The product contains 15 mg of polynucleotides per 2 mL syringe (7.5 mg/mL) and is intended strictly for professional use.
主なメリット: Pluryal Hair Density
- Supports follicular stimulation through activation of dermal papilla cell activity
- Improves hair cycle dynamics, increasing the anagen/telogen ratio and reducing premature miniaturisation
- Provides anti-inflammatory action, reducing inflammatory mediators in the scalp
- Supports microcirculation, enhancing local perfusion, oxygenation and nutrient supply
- Promotes structural reinforcement around the follicle bulge, helping reduce hair shedding
- CE-marked Class III medical device for professional use
適応と専門的な使用
主な適応
- Androgenetic alopecia (in women and men)
- Telogen effluvium
- Adjuvant therapy: post-hair-transplant support, LED light and PRP
専門的な使用
Pluryal Hair Density is a class III medical device for professional use only, reserved for trained medical practitioners. It is administered by intradermal injection into the deep dermis of the scalp using a microbolus, multi-puncture or linear threading technique. Indicated for androgenetic alopecia, telogen effluvium and as adjuvant therapy after hair transplant, LED light or PRP. For androgenetic alopecia the protocol is 10 sessions over 4 months, followed by monthly maintenance.
施術部位
- Scalp: frontotemporal region, mid-scalp and vertex
- Eyebrows
- Beard
対象となる患者
Suitable for adult men and women across androgenetic alopecia stages I-IV, with telogen effluvium, or requiring post-transplant support, following clinical assessment. A clinical study of 20 patients (10 men, 10 women; mean age 37.7 ± 8.1) published in the Archives of Dermatological Research reported a significant reduction in hair shedding, an increased anagen/telogen ratio, a 24.2% increase in terminal hairs at week 24 and improved hair thickness, with only mild, transient adverse effects and no serious adverse events.
作用の仕組み: Pluryal Hair Density
Pluryal Hair Density works through polynucleotides at 7.5 mg/mL, injected intradermally into the scalp to activate metabolic pathways and A2A purinergic receptors that promote dermal papilla cell activity. This supports improved hair cycle dynamics, reduces inflammatory mediators, enhances local microcirculation, and promotes structural reinforcement around the follicle bulge, together supporting scalp and hair regeneration in androgenetic alopecia, telogen effluvium and post-transplantation recovery.
Allparaで注文する理由
Allparaは、正規品で検証済みの PLURYAL 製品を厳選されたサプライヤーから提供し、完全なロットトレーサビリティと専門家によるサポートを備えています。CE認証製品、EU倉庫からのEU全域への迅速な配送、競争力のある業務用価格で、クリニックと美容医療の専門家にサービスを提供しています。私たちが重視するのは患者様の安全、満足、そして結果です。安心してご利用いただけるよう、専任のアフターサポートをご用意しています。
よくある質問
On which areas is Pluryal Hair Density used?
The scalp (the frontotemporal region, mid-scalp and vertex) as well as the eyebrows and beard, for androgenetic alopecia, telogen effluvium and post-hair-transplant support.
Is there clinical evidence for Pluryal Hair Density?
Yes. A clinical study of 20 patients with androgenetic alopecia, published in the Archives of Dermatological Research, reported a significant reduction in hair shedding, an increased anagen/telogen ratio and a 24.2% increase in terminal hairs at week 24, with no serious adverse events.
How many sessions of Pluryal Hair Density are needed?
For androgenetic alopecia the recommended course is 10 intradermal sessions over 4 months, followed by monthly maintenance. For telogen effluvium the course is 3 monthly sessions, repeated after 6 months if needed.
その他の製品: MD Skin solutions Laboratoires
Clinic alternatives
Pick up where you left off
Pluryal Hair Density
Pluryal Hair Density is a sterile, ready-to-use, CE-marked injectable polynucleotide (PN) biostimulator, formulated for scalp and hair regeneration. It is reserved for medical practitioners only and is indicated for hair loss conditions such as androgenetic alopecia and telogen effluvium, as well as for support after hair transplantation. The product contains 15 mg of polynucleotides per 2 mL syringe (7.5 mg/mL) and is intended strictly for professional use.
主なメリット: Pluryal Hair Density
- Supports follicular stimulation through activation of dermal papilla cell activity
- Improves hair cycle dynamics, increasing the anagen/telogen ratio and reducing premature miniaturisation
- Provides anti-inflammatory action, reducing inflammatory mediators in the scalp
- Supports microcirculation, enhancing local perfusion, oxygenation and nutrient supply
- Promotes structural reinforcement around the follicle bulge, helping reduce hair shedding
- CE-marked Class III medical device for professional use
適応と専門的な使用
主な適応
- Androgenetic alopecia (in women and men)
- Telogen effluvium
- Adjuvant therapy: post-hair-transplant support, LED light and PRP
専門的な使用
Pluryal Hair Density is a class III medical device for professional use only, reserved for trained medical practitioners. It is administered by intradermal injection into the deep dermis of the scalp using a microbolus, multi-puncture or linear threading technique. Indicated for androgenetic alopecia, telogen effluvium and as adjuvant therapy after hair transplant, LED light or PRP. For androgenetic alopecia the protocol is 10 sessions over 4 months, followed by monthly maintenance.
施術部位
- Scalp: frontotemporal region, mid-scalp and vertex
- Eyebrows
- Beard
対象となる患者
Suitable for adult men and women across androgenetic alopecia stages I-IV, with telogen effluvium, or requiring post-transplant support, following clinical assessment. A clinical study of 20 patients (10 men, 10 women; mean age 37.7 ± 8.1) published in the Archives of Dermatological Research reported a significant reduction in hair shedding, an increased anagen/telogen ratio, a 24.2% increase in terminal hairs at week 24 and improved hair thickness, with only mild, transient adverse effects and no serious adverse events.
作用の仕組み: Pluryal Hair Density
Pluryal Hair Density works through polynucleotides at 7.5 mg/mL, injected intradermally into the scalp to activate metabolic pathways and A2A purinergic receptors that promote dermal papilla cell activity. This supports improved hair cycle dynamics, reduces inflammatory mediators, enhances local microcirculation, and promotes structural reinforcement around the follicle bulge, together supporting scalp and hair regeneration in androgenetic alopecia, telogen effluvium and post-transplantation recovery.
Allparaで注文する理由
Allparaは、正規品で検証済みの PLURYAL 製品を、完全なロットトレーサビリティ、CE認証在庫、EU全域への迅速な配送、専門的なアフターサポートとともに提供しています。
よくある質問
On which areas is Pluryal Hair Density used?
The scalp (the frontotemporal region, mid-scalp and vertex) as well as the eyebrows and beard, for androgenetic alopecia, telogen effluvium and post-hair-transplant support.
Is there clinical evidence for Pluryal Hair Density?
Yes. A clinical study of 20 patients with androgenetic alopecia, published in the Archives of Dermatological Research, reported a significant reduction in hair shedding, an increased anagen/telogen ratio and a 24.2% increase in terminal hairs at week 24, with no serious adverse events.
How many sessions of Pluryal Hair Density are needed?
For androgenetic alopecia the recommended course is 10 intradermal sessions over 4 months, followed by monthly maintenance. For telogen effluvium the course is 3 monthly sessions, repeated after 6 months if needed.